跳到正文
研踪PaperTrail
← 研踪 PaperTrail

arXiv:2409.04970 · v3

A response-adaptive multi-arm design for continuous endpoints based on a weighted information measure

首次提交 2024-09-08 12:30
版本更新 2026-11-17 22:35
雷达观测 2026-11-18 16:38
arXiv ↗PDF ↗

摘要

Multi-arm trials are gaining interest in practice given the statistical and logistical advantages they can offer. The standard approach uses a fixed allocation ratio, but there is a call for making it adaptive and skewing the allocation of patients towards better-performing arms. However, it is well-known that these approaches might suffer from lower statistical power. We present a response-adaptive design for continuous endpoints which explicitly allows to control the trade-off between the number of patients allocated to the "optimal" arm and the statistical power. Such a balance is achieved through the calibration of a tuning parameter, and we explore robust procedures to select it. The proposed criterion is based on a context-dependent information measure which gives greater weight to treatment arms with characteristics close to a pre-specified clinical target. We establish conditions under which the procedure consistently selects the target arm and derive the corresponding limiting allocation ratios. We also introduce a simulation-based hypothesis testing procedure which focuses on selecting the target arm and discuss strategies to effectively control the type-I error rate. The practical implementation of the proposed criterion and its potential advantage over currently used alternatives are illustrated in the context of early Phase IIa proof-of-concept oncology trials.

作者备注:Accepted for publication in Journal of the Royal Statistical Society Series B: Statistical Methodology

AI 论文解读

基于摘要 · 非全文审阅

此版本尚未生成 AI 解读。解读由后台任务生成并按论文版本保存,登录后共享已有结果。

版本差异

本站首次收录为 v3,暂无更早版本可对照。

观测到的版本

相邻记录可能跳过中间版本;首次发现 v2 及以上也会标为版本更新。

v3 · 2026-11-17 22:35 · 最新观测版本

A response-adaptive multi-arm design for continuous endpoints based on a weighted information measure

Multi-arm trials are gaining interest in practice given the statistical and logistical advantages they can offer. The standard approach uses a fixed allocation ratio, but there is a call for making it adaptive and skewing the allocation of patients towards better-performing arms. However, it is well-known that these approaches might suffer from lower statistical power. We present a response-adaptive design for continuous endpoints which explicitly allows to control the trade-off between the number of patients allocated to the "optimal" arm and the statistical power. Such a balance is achieved through the calibration of a tuning parameter, and we explore robust procedures to select it. The proposed criterion is based on a context-dependent information measure which gives greater weight to treatment arms with characteristics close to a pre-specified clinical target. We establish conditions under which the procedure consistently selects the target arm and derive the corresponding limiting allocation ratios. We also introduce a simulation-based hypothesis testing procedure which focuses on selecting the target arm and discuss strategies to effectively control the type-I error rate. The practical implementation of the proposed criterion and its potential advantage over currently used alternatives are illustrated in the context of early Phase IIa proof-of-concept oncology trials.

查看此版本解读 →查看此版本原文 ↗